These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2881902)

  • 1. Ecstacy: a review of MDMA and MDA.
    Climko RP; Roehrich H; Sweeney DR; Al-Razi J
    Int J Psychiatry Med; 1986-1987; 16(4):359-72. PubMed ID: 2881902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenomenology and sequelae of 3,4-methylenedioxymethamphetamine use.
    Liester MB; Grob CS; Bravo GL; Walsh RN
    J Nerv Ment Dis; 1992 Jun; 180(6):345-52; discussion 353-4. PubMed ID: 1350613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subjective reports of the effects of MDMA in a clinical setting.
    Greer G; Tolbert R
    J Psychoactive Drugs; 1986; 18(4):319-27. PubMed ID: 2880946
    [No Abstract]   [Full Text] [Related]  

  • 4. Information on "Ecstasy".
    Greer G; Strassman RJ
    Am J Psychiatry; 1985 Nov; 142(11):1391. PubMed ID: 2865906
    [No Abstract]   [Full Text] [Related]  

  • 5. MDMA (3,4-methylenedioxymethamphetamine): proceedings of the conference. May 17-18, 1986, Oakland, California.
    J Psychoactive Drugs; 1986; 18(4):287-379. PubMed ID: 2880942
    [No Abstract]   [Full Text] [Related]  

  • 6. Discriminative stimulus properties of (+/-)-3,4-methylenedioxymethamphetamine and (+/-)-3,4-methylenedioxyamphetamine in pigeons.
    Evans SM; Johanson CE
    Drug Alcohol Depend; 1986 Oct; 18(2):159-64. PubMed ID: 2877843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MDMA and human sexual function.
    Buffum J; Moser C
    J Psychoactive Drugs; 1986; 18(4):355-9. PubMed ID: 2880951
    [No Abstract]   [Full Text] [Related]  

  • 8. Tolerance and cross-tolerance to 3,4-methylenedioxymethamphetamine (MDMA), methamphetamine and methylenedioxyamphetamine.
    Zacny JP; Virus RM; Woolverton WL
    Pharmacol Biochem Behav; 1990 Mar; 35(3):637-42. PubMed ID: 1971112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users.
    Peroutka SJ; Newman H; Harris H
    Neuropsychopharmacology; 1988 Dec; 1(4):273-7. PubMed ID: 2908020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Designer drug confusion: a focus on MDMA.
    Beck J; Morgan PA
    J Drug Educ; 1986; 16(3):287-302. PubMed ID: 2877058
    [No Abstract]   [Full Text] [Related]  

  • 11. Behavioral effects of (+-) 3,4-methylenedioxyamphetamine (MDA) and (+-) 3,4-methylenedioxymethamphetamine (MDMA) in the pigeon: interactions with noradrenergic and serotonergic systems.
    Nader MA; Hoffmann SM; Barrett JE
    Psychopharmacology (Berl); 1989; 98(2):183-8. PubMed ID: 2569215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in the stimulus properties of 3,4-methylenedioxyamphetamine and 3,4- methylenedioxymethamphetamine in animals trained to discriminate hallucinogens from saline.
    Callahan PM; Appel JB
    J Pharmacol Exp Ther; 1988 Sep; 246(3):866-70. PubMed ID: 2901488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of optical isomers of 3,4-methylenedioxymethamphetamine (MDMA) on stereotyped behavior in rats.
    Hiramatsu M; Nabeshima T; Kameyama T; Maeda Y; Cho AK
    Pharmacol Biochem Behav; 1989 Jun; 33(2):343-7. PubMed ID: 2573077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MDMA reconsidered.
    Leverant R
    J Psychoactive Drugs; 1986; 18(4):373-9. PubMed ID: 2880955
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain.
    Stone DM; Stahl DC; Hanson GR; Gibb JW
    Eur J Pharmacol; 1986 Aug; 128(1-2):41-8. PubMed ID: 2875893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-administration of methylenedioxymethamphetamine (MDMA) by rhesus monkeys.
    Beardsley PM; Balster RL; Harris LS
    Drug Alcohol Depend; 1986 Oct; 18(2):149-57. PubMed ID: 2877842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The MDMA-neurotoxicity controversy: implications for clinical research with novel psychoactive drugs.
    Grob CS; Bravo GL; Walsh RN; Liester MB
    J Nerv Ment Dis; 1992 Jun; 180(6):355-6. PubMed ID: 1350614
    [No Abstract]   [Full Text] [Related]  

  • 18. The background and chemistry of MDMA.
    Shulgin AT
    J Psychoactive Drugs; 1986; 18(4):291-304. PubMed ID: 2880943
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of (+/-)-methylenedioxymethamphetamine and (+/-)-methylenedioxyamphetamine in monkeys trained to discriminate (+)-amphetamine from saline.
    Kamien JB; Johanson CE; Schuster CR; Woolverton WL
    Drug Alcohol Depend; 1986 Oct; 18(2):139-47. PubMed ID: 2877841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychostimulant properties of MDMA.
    Gold LH; Geyer MA; Koob GF
    NIDA Res Monogr; 1989; 95():345-6. PubMed ID: 2577038
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.